NG
PFE icon

Novem Group’s Pfizer PFE Stock Holding History

Novem Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$347K Sell
14,402
-187
-1% -$4.89K 0.04% 333
2026
Q1 		$410K Sell
14,589
-1,471
-9% -$39.2K 0.05% 298
2025
Q4 		$400K Buy
16,060
+712
+5% +$18K 0.05% 299
2025
Q3 		$391K Sell
15,348
-264
-2% -$6.52K 0.05% 295
2025
Q2 		$378K Buy
15,612
+282
+2% +$6.58K 0.05% 284
2025
Q1 		$388K Buy
15,330
+1,064
+7% +$27.8K 0.05% 256
2024
Q4 		$378K Buy
+14,266
New +$387K 0.06% 260

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Novem Group's PFE Position: Q2 2026 in Review

Novem Group reduced its Pfizer (PFE) stake by 1.3% in Q2 2026, selling an estimated $4.89K and leaving 14,402 shares worth $347K. The position accounts for 0.04% of the portfolio, ranked #333.

Novem Group first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $410K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Novem Group held 14,402 shares of Pfizer worth $347K as of Q2 2026.
  • Novem Group sold 187 Pfizer shares in Q2 2026, an estimated $4.89K.
  • Pfizer made up 0.04% of Novem Group's portfolio in Q2 2026, its #333 holding.
  • Novem Group first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Novem Group's Pfizer position peaked at $410K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.